| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ciclosporin | CTRPv2 | pan-cancer | AAC | -0.0035 | 0.9 |
| mRNA | FH535 | GDSC1000 | pan-cancer | AAC | -0.0031 | 0.9 |
| mRNA | MG-132 | GDSC1000 | pan-cancer | AAC | 0.0042 | 0.9 |
| mRNA | ML083 | CTRPv2 | pan-cancer | AAC | 0.0034 | 0.9 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | -0.003 | 0.9 |
| mRNA | SMER-3 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | tivozanib | CTRPv2 | pan-cancer | AAC | -0.0029 | 0.9 |
| mRNA | JW-74 | CTRPv2 | pan-cancer | AAC | 0.0036 | 0.9 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.0031 | 0.9 |
| mRNA | BRD-K16147474 | CTRPv2 | pan-cancer | AAC | 0.0029 | 0.9 |